Current Progress and Challenges in the Study of Adjuvants for Oral Vaccines

BioDrugs. 2023 Mar;37(2):143-180. doi: 10.1007/s40259-022-00575-1. Epub 2023 Jan 6.

Abstract

Over the past 20 years, a variety of potential adjuvants have been studied to enhance the effect of oral vaccines in the intestinal mucosal immune system; however, no licensed adjuvant for clinical application in oral vaccines is available. In this review, we systematically updated the research progress of oral vaccine adjuvants over the past 2 decades, including biogenic adjuvants, non-biogenic adjuvants, and their multi-type composite adjuvant materials, and introduced their immune mechanisms of adjuvanticity, aiming at providing theoretical basis for developing feasible and effective adjuvants for oral vaccines. Based on these insights, we briefly discussed the challenges in the development of oral vaccine adjuvants and prospects for their future development.

Publication types

  • Review

MeSH terms

  • Adjuvants, Immunologic
  • Adjuvants, Vaccine*
  • Humans
  • Vaccines*

Substances

  • Adjuvants, Vaccine
  • Adjuvants, Immunologic
  • Vaccines